Liver-specific MR imaging contrast agents

Radiologic Clinics of North America

Volumn 36, Issue 2, 1998, Pages 287-297

  Hahn, P F ^a   Saini, S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; ECHOVIST; GADOBENATE DIMEGLUMINE; GADOBENIC ACID; GADOLINIUM CHELATE; GADOXETIC ACID; IRON OXIDE; MANGAFODIPIR; SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

COLON CANCER; CONTRAST ENHANCEMENT; HEMANGIOMA; IMAGE ANALYSIS; IMAGE QUALITY; LIVER CIRRHOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CARCINOMA; PRIORITY JOURNAL; REVIEW;

EID: 0031956041     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-8389(05)70022-1     Document Type: Article

References (56)

1. K.P. Aicher M. Laniado A.F. Kopp Mn-DPDP-enhanced MR imaging of malignant liver lesions: Efficacy and safety in 20 patients J Magn Reson Imaging 3 1993 731 737
2. T. Balzer E.C. Carter K. Shamsi Results of a multicenter phase II clinical trial with a susceptibility contrast medium for magnetic resonance imaging of the liver Acad Radiol 3 suppl 2 1996 S417 S419
3. R.L. Baron M.S. Peterson F.L. Thaete Liver tumor detection: Comparison of Gd-BOPTA-enhanced MR, contrast-enhanced CT, and CT arterial portography [abstract] Radiology 197 P 1995 415
4. M.F. Bellin S. Zaim E. Auberton Liver metastases: Safety and efficacy of detection with superparamagnetic iron oxide in MR imaging Radiology 193 1994 657 663
5. R. Caudana G. Morana G.P. Pirovano Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA): Preliminary results of phase II clinical application Radiology 199 1996 513 520
6. J.L. Chezmar R.D. Redvanly C.W. Sewell Uptake of mangafodipir trisodium (Mn-DPDP) by hepatocellular carcinoma: Correlation with unenhanced imaging findings and histopathologic features Acad Radiol 3 1996 S413 S414
7. O. Clement A. Mühler V. Vexler Gadolinium-ethoxybenzyl-DTPA: A new liver-specific magnetic resonance contrast agent-kinetic and enhancement patterns in normal and cholestatic rats Invest Radiol 27 1992 612 619
8. C. de Haën L. Gozzini Soluble-type hepatobiliary contrast agents for MR imaging J Magn Reson Imaging 3 1993 179 186
9. S.H. Duda M. Laniado A.F. Kopp Superparamagnetic iron oxide: Detection of focal liver lesions at high-field-strength MR imaging J Magn Reson Imaging 4 1994 309 314
10. J.P. Earls N.D. Theise J.C. Weinreb Dysplastic nodules and hepatocellular carcinoma: Thin-section MR imaging of explanted cirrhotic livers with pathologic correlation Radiology 201 1996 207 214
11. G. Elizondo R. Weissleder D.D. Stark Hepatic cirrhosis and hepatitis: MR imaging enhanced with superparamagnetic iron oxide Radiology 174 1990 797 801
12. W.S. Enochs R. Weissleder Organ and tissue-directed MRI contrast agents ed 2 R.R. Edelman J.R. Hesselink M.B. Zlatkin Clinical Magnetic Resonance Imaging vol 1 1996 WB Saunders Philadelphia 192 220
13. A.K. Fahlvik J. Klaveness D.D. Stark Iron oxides as MR imaging contrast agents J Magn Reson Imaging 3 1993 187 194
14. C.J. Fretz G. Elizondo R. Weissleder Superparamagnetic iron oxide-enhanced MR imaging: Pulse sequence optimization for detection of liver cancer Radiology 172 1989 393 397
15. T. Fukuya H. Honda T. Maeda Well-differentiated hepatocellular carcinoma: Isointense to liver parenchyma on superparamagnetic iron oxide-enhanced MR Radiat Med 13 1995 35 37
16. C. Grandin B.E. Van Beers A. Robert Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration J Comput Assist Tomogr 19 1995 412 418
17. C. Grangier J. Tourniaire G. Mentha Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles J Comput Assist Tomogr 18 1994 888 896
18. K.D. Hagspiel K.F. Neidl A.C. Eichenberger Detection of liver metastases: Comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US Radiology 196 1995 471 478
19. P.F. Hahn D.D. Stark R. Weissleder Superparamagnetic iron oxide: Clinical application to imaging tissue perfusion in vascular liver tumors Radiology 174 1990 361 366
20. B. Hamm T. Staks A. Mühler Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: Safety, pharmacokinetics, and MR imaging Radiology 195 1995 785 792
21. M.G. Harisinghani S. Saini R. Weissleder Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent Code-7227 Radiology 202 1997 687 691
22. L. Josephson J. Lewis P. Jacobs The effects of iron oxides on proton relaxivity Magn Reson Imaging 6 1988 647 653
23. P. Karhunen Benign hepatic tumors and tumor-like conditions in men J Clin Pathol 39 1986 183 187
24. A.F. Kopp M. Laniado F. Dammann MR imaging of the liver with Resovist: Safety, efficacy, and pharmacodynamic properties Radiology 204 1997 749 756
25. J. Liou J.K. Lee J.A. Borrello Differentiation of hepatomas from nonhepatomatous masses: Use of MnDPDP-enhanced MR images Magn Reson Imaging 12 1994 71 79
26. G. Marchal P.V. Hecke P. Demaerel Detection of liver metastases with superparamagnetic iron oxide in 15 patients: Results of MR imaging at 1.5 T AJR Am J Roentgenol 152 1989 771 775
27. W.W. Mayo-Smith S. Saini MR contrast material for vascular enhancement: Value of superparamagnetic iron oxide AJR Am J Roentgenol 166 1996 73 77
28. P.J. Mergo T. Helmberger A.I. Nicolas Ring enhancement in ultrasmall superparamagnetic iron oxide MR imaging: A potential new sign for characterization of liver lesions AJR Am J Roentgenol 166 1996 379 384
29. D.G. Mitchell Hepatobiliary contrast material: A magic bullet for sensitivity and specificity? Radiology 188 1993 21 22
30. T. Murakami R.L. Baron M.S. Peterson Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP) Radiology 200 1996 69 77
31. J. Petersein S. Saini R. Weissleder Liver II: Iron oxide-based reticuloendothelial contrast agents for MR imaging Magnetic Reson Imaging Clin N Am 4 1996 53 60
32. V.M. Phillips B.C. Erwin M.E. Bernardino Delayed iodine scanning of the liver: A promising CT technique J Comput Assist Tomogr 9 1985 415 616
33. P. Reimer K.K. Kwong R. Weisskoff Dynamic signal intensity changes in liver with superparamagnetic MR contrast agents J Magn Reson Imaging 2 1992 177 181
34. P. Reimer E.J. Rummeny H.E. Daldrup Clinical results with Resovist: A phase 2 clinical trial Radiology 195 1995 489 496
35. P. Reimer E.J. Rummeny H.E. Daldrup Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: Preliminary results with dynamic MR imaging Eur Radiol 7 1997 275 280
36. P. Reimer B. Tomback H. Daldrup New MR contrast agents in the diagnosis of liver lesions. Preliminary clinical experience with the hepatobiliary Eovist (gadolinium-EOB-DTPA) and the RES-specific Resovist (SH U 555 A) Radiologe 36 1996 124 133
37. S.M. Rocklage M. van Wagoner Hepatobiliary contrast agents: An overview of the development of manganese dipyridoxyl diphosphate (Mn-DPDP) J.T. Ferrucci D.D. Stark Liver Imaging: Current Trends and New Techniques. 1990 Andover Medical Boston 374 383
38. N.M. Rofsky J.C. Weinreb M.E. Bernardino Hepatocellular tumors: Characterization with Mn-DPDP-enhanced MR imaging Radiology 188 1993 53 59
39. P.R. Ros P.C. Freeny S.E. Harms Hepatic MR imaging with ferumoxides: A multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions Radiology 196 1995 481 488
40. E.J. Rummeny C. Ehrenheim H.B. Gehl Manganese-DPDP as a hepatobiliary contrast agent in MR imaging of liver tumors: Results of clinical phase II trials in Germany including 141 patients Invest Radiol 27 1992 879 886
41. S. Saini R.R. Edelman P. Sharma Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: Initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227) AJR Am J Roentgenol 164 1995 1147 1152
42. L.H. Schwartz S.E. Seltzer C.M. Tempany Superparamagnetic iron oxide hepatic MR imaging: Efficacy and safety using conventional and fast spin-echo pulse sequences J Magn Reson Imaging 5 1995 566 570
43. E. Senéterre P. Taourel Y. Bouvier Detection of hepatic metastases: Ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography Radiology 200 1996 785 792
44. G.J. Slater S. Saini W.W. Mayo-smith Mn-DPDP enhanced MR imaging of the liver: Analysis of pulse sequence performance Clin Radiol 51 1996 484 486
45. D.D. Stark R.E. Hendrick P.F. Hahn Motion artifact reduction with fast spin echo imaging Radiology 164 1987 183 191
46. D.D. Stark R. Weissleder G. Elizondo Superparamagnetic iron oxide: Clinical application as a contrast agent for MR imaging of the liver Radiology 168 1988 297 301
47. A. Tanimoto D. Pouliquen B.P. Kreft Effects of spatial distribution on proton relaxation enhancement by particulate iron oxide J Magn Reson Imaging 4 1994 653 657
48. P.M. Taylor J.M. Hawnaur C.E. Hutchinson Superparamagnetic iron oxide imaging of focal liver disease Clin Radiol 50 1995 215 219
49. T.J. Vogl B. Hamm B. Schnell Mn-DPDP enhancement patterns of hepatocellular lesions on MR images J Magn Reson Imaging 3 1993 51 58
50. T.J. Vogl R. Hammerstingl W. Schwarz Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide Resovist versus gadolinium-DTPA in the same patient Invest Radiol 31 1996 696 708
51. T.J. Vogl R. Hammerstingl W. Schwarz Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions Radiology 198 1996 881 887
52. T.J. Vogl S. Kümmel R. Hammerstingl Liver tumors: Comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA Radiology 200 1996 59 67
53. H. Yamamoto Y. Yamashita S. Yoshimatsu Hepatocellular carcinoma in cirrhotic livers: Detection with unenhanced and iron oxide-enhanced MR imaging Radiology 195 1995 106 112
54. Y. Yamashita H. Yamamoto A. Hirai MR imaging enhancement with superparamagnetic iron oxide in chronic liver disease: Influence of liver dysfunction and parenchymal pathology Abdom Imaging 21 1996 318 323
55. R. Weissleder Liver MR imaging with iron oxides: Toward consensus and clinical practice Radiology 193 1994 593 595
56. T.C. Winter 3d P.C. Freeny MR imaging with i.v. superparamagnetic iron oxide: Efficacy in the detection of focal hepatic lesions AJR Am J Roentgenol 161 1993 1191 1198